Avra Laboratories Pvt Ltd
www.avralab.comAvra Labs was established in the year 1995 and is among the first in India to focus on providing high-end contract research and manufacturing of advanced intermediates and APIs covering oncology and other therapeutic areas. Today, with our strong team of 600+ employees, we are focused on providing custom synthesis solutions across the value chain, right from developing a cost-effective process to supplying commercial quantities from our facilities, which include USFDA and GMP approved sites. Being founded by one of India's most distinguished scientists, Dr. A. V. Rama Rao (https://en.wikipedia.org/wiki/A._V._Rama_Rao), we take pride in our cutting edge chemistry capabilities. We are the only company in the world to develop and successfully commercialize a synthetic process for Irinotecan, and have partnered with some of the largest global innovators to develop advanced intermediates and supply them at a commercial scale post-launch. Our state-of-the-art manufacturing facilities are spread over 30 acres with a total reactor volume over 165.000 liters, located in Hyderabad (USFDA approved) and Vizag. Please visit our website for more information (www.avralab.com) and reach out to us at info@avralab.com for anything you may need.
Read moreAvra Labs was established in the year 1995 and is among the first in India to focus on providing high-end contract research and manufacturing of advanced intermediates and APIs covering oncology and other therapeutic areas. Today, with our strong team of 600+ employees, we are focused on providing custom synthesis solutions across the value chain, right from developing a cost-effective process to supplying commercial quantities from our facilities, which include USFDA and GMP approved sites. Being founded by one of India's most distinguished scientists, Dr. A. V. Rama Rao (https://en.wikipedia.org/wiki/A._V._Rama_Rao), we take pride in our cutting edge chemistry capabilities. We are the only company in the world to develop and successfully commercialize a synthetic process for Irinotecan, and have partnered with some of the largest global innovators to develop advanced intermediates and supply them at a commercial scale post-launch. Our state-of-the-art manufacturing facilities are spread over 30 acres with a total reactor volume over 165.000 liters, located in Hyderabad (USFDA approved) and Vizag. Please visit our website for more information (www.avralab.com) and reach out to us at info@avralab.com for anything you may need.
Read moreCountry
City (Headquarters)
Hyderābād
Industry
Employees
501-1000
Founded
1995
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President
Email ****** @****.comPhone (***) ****-****Chief Operating Officer and Director
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Ehs Executive
Email ****** @****.comPhone (***) ****-****
Technologies
(17)